2018 Speakers




Amkidit Afable, Director Go-to-Market Strategies, Johnson & Johnson, Singapore

Amkidit Afable at Phar-East 2018

Anushree Agarwal, Senior Manager - Launch Readiness & Excellence For Emerging Markets, Takeda, Singapore

Anushree Agarwal at Phar-East 2018

Pritha Aggarwal, Scientific Officer, IAVI, India

Christopher Ahn, Researcher, Biosolution Co., Ltd., Republic Of Korea

Solomon Alva, Antibody Purification Group Head, Senior Scientific Manager, Biocon Limited, India

Ines Atmosukarto, Chief Scientific Officer and Managing Director, Lipotek Pty Ltd, Australia

Seong Min Baek, South East Asia Regional Manager, Macrogen, Singapore

Lalit Baregama, General Manager of Global Business Development, Cadila Pharmaceutical Ltd., India

Lalit Baregama at Phar-East 2018

Kaustubh Berde, Vice President for International Business : Emerging Markets, Wockhardt Limited, India

Antonio Bertoletti, Co-Founder, Lion TCR, Singapore

Himanshu Brahmbhatt, Joint CEO & Director, EnGeneIC Pty Ltd, Australia

Himanshu Brahmbhatt at Phar-East 2018

Robert Bruno, Director of Clinical Operations, Abbvie Japan, Japan

Peter Burkhardt, Patent examiner, European Patent Office

Peter Burkhardt at Phar-East 2018

Lynlee Burton, Director of Project Delivery - Vaccines, PRA Health Sciences, United States

Jerome Cabannes, Chief Operating Officer, AJ Biologics, Malaysia

James Cai, VP, Regulatory Affairs, JAPAC, Amgen, China

Matteo Carli, CTO & Co-Founder, Xbird, Bayer’s Grants4Apps, Germany

Hardy Chan, Founder and Chairman, Allianz Pharmascience, Taiwan

Shau-Feng Chang, Chief Executive Officer and Chief Scientific Officer, BELX Bio-Pharmaceutical, Taiwan

Shao Siong Chua, Head of Manufacturing, Novartis Singapore Pte Ltd, Singapore

Nigel Clarke, Manager Patent Information, European Patent Office, Austria

Erick Co, Chief Scientific Officer, Formosa Pharmaceuticals, Taiwan

John Connolly, Chief Scientific Officer, Tessa Therapeutics, Singapore

Thomas Cornell, Senior Scientist, ACM Biolabs, Singapore

Tagle Danilo A, Associate Director for Special Initiatives, National Center for Advancing Translational Sciences, United States

Ariane Davison, Consultant Advisor, Hummingbird Bioscience, China

Ariane Davison at Phar-East 2018

Ayan Dey, Scientist, International Vaccine Institute, Republic Of Korea

Manish Garg, Medical Director, MSD, Singapore

Manish Garg at Phar-East 2018

James Garner, Chief Executive Officer & Managing Director, Kazia Therapeutics Limited, Singapore

James Garner at Phar-East 2018

Stewart Geary, Senior Vice President, Chief Medical Officer, Director, Corporate Medical Affairs Headquarters, Eisai, Japan

Bobby George, VP & Head Regulatory Affairs, Reliance Life Sciences, India

Stefan Glück, Vice President of Global Medical Affairs, Celgene, United States of America

Shwen Gwee, Head of Digital Strategy, Global Clinical Operations, Biogen, United States

Carrie Hillyard, Chairman, FitGenes, Australia

Carrie Hillyard at Phar-East 2018

David Hou, Head of Site and Patient Network, IQVIA, Singapore

Sean Hsiao, Vice President, Top Taiwan Venture Capital, Taiwan

Forrest Hu, General Manager of International Business, 3SBio Inc, China

Sean-Lin Huang, CEO, Amwise Diagnostics, Taiwan

Jerry Huang, Business Development Associate Director, Lin BioScience, Taiwan

James Huang, Regional Medical Director Oncology Asia Pacific, Merck Pte. Ltd., Singapore

Abha Inamdar, Assistant Vice President, Private Equity Innovation Funds, Tata Capital Limited, India

Yuliana Indriati, President Director, Pt. Kalbe Genexine Biologics, Indonesia

Astrid Irwanto, Co-Founder, Nalagenetics, Singapore

Mrunalini Jagtap, Data Management Lead, SICS, A*STAR, Singapore

Jacob Jensen, Senior Manager, Technology Transfer, Biogen, Denmark

Haseop Jeong, CSO, Proteina, Republic Of Korea

Santosh Jha, Director of Medical Regulatory, Takeda, India

Santosh Jha at Phar-East 2018

Kenji Kakuta, President and Chief Executive Officer, iHeart Japan Corporation, Japan

Kesavan Karthikeyan, Assistant Professor, Guru Ghasidas Central University, India

Yun Hee Kim, Senior Researcher, JD Bioscience, Republic Of Korea

Eugene Kim, Director of Overseas Business Development, Bioinfra Life Science, Inc., Republic Of Korea

Prabhuram Krishnan, Medical Director, Ipsen, Malaysia

Prabhuram Krishnan at Phar-East 2018

Dinesh Kundu, CEO & Co-Founder, Q Biosciences, India

Yichung Law, Head of Biomedical Sciences, Singapore Economic Development Board, Singapore

Yichung Law at Phar-East 2018

Kate Lawrey, Associate Director, Operations Lead – Asia Next Generation Clinical Development, IQVIA, Singapore

Kate Lawrey at Phar-East 2018

Jae Sam Lee, Director, MDimune, Republic Of Korea

Antonio Lee, Chief Executive Officer & Managing Director, MEDIPOST America, Republic Of Korea

Victor Li, CEO, Lion TCR, Singapore

Ivor Lim, Founding Director & Group Chief Medical Officer, Cellresearch Corporation, Singapore

Tony Liu, CEO& CFO, Cellular Biomedicine Group, Inc, China

Tony Liu at Phar-East 2018

Yan Fang Liu, Senior Director, Epidemiology Lead for Asia Pacific, Johnson & Johnson, Singapore

Levent Liu, Investigator, Vaccines R&D, National Health Research Institutes Taiwan, Taiwan

Robin Low, CEO, Areteon Pte Ltd., Singapore

Tzu-Pin Lu, National Taiwan University, Taiwan

Oscar Luo, Research Scientist, Australian E-Health Research Centre, CSIRO Australian Animal Health Laboratory, Australia

Hui Hsing Ma, Senior Advisor, TVM Capital Healthcare Partners, Germany

Prasanta Kumar Maiti, Principal Scientist, Imgenex India Pvt. Ltd, India

B N Manohar, CEO, Stempeutics Research, India

Joseph Mocanu, Principal, Life Sciences and Digital Health, Oliver Wyman, Singapore

John Moore, Director of Global Clinical Business Development, Vetter Pharma International GmbH, United States

Tetsuya Nakatsura, Chief of Division of Cancer Immunotherapy, National Cancer Center Japan, Japan

Carolyn Ng, Vice President, Vertex Ventures, Singapore

Trần Hiển Nguyễn, Former Director, National Institute of Hygiene and Epidemiology, Vietnam

Seiji Okada, Professor, Center for AIDS Research & Graduate School of Medical Sciences, Kumamoto University, Japan

Jisoo Pae, CEO, Genome & company, Republic Of Korea

Marimuthu Palaniswami, Professor, Director, University of Melbourne, Australia

Ying Pan, Director of Translational Science, CStone, China

Woong Yang Park, Director, Samsung Genome Institute, Republic Of Korea

Benjamin Petsch, Head of Vaccines, CureVac Gmbh, Germany

Hung Fai Poon, President, QuaCell Biotech Ltd, China

Brad Pruitt, Executive Director, Chief Medical Officer, Parallel 6, United States

Malini Raj, Non Executive Director, World Alliance of Pituitary Organisations (WAPO), Australia

Dr GS Reddy, Chief General Manager, Manufacturing, Indian Immunologicals Ltd, India

Ahmad Redzuan Sidek, Chief Investment Officer, ABio Sdn Bhd, Malaysia

Ahmad Redzuan Sidek at Phar-East 2018

Jason Rushton, Investment Partner, Xeraya Capital Sdn Bhd, Malaysia

Uday Saxena, Chief Scientific Officer, Dr Reddy's Laboratory, United States

Alfred Scheidegger, Founder and Partner, Nextech Invest, Switzerland

Sakthivel Sekar, CEO & Co founder, Sinopsee Therapeutics, Singapore

Bandana Sharan, President, Director, Research, APAC Biotech, India

Prathibha Shetty, Head, Regenerative Medicine Group, Reliance Life Sciences, India

Norio Shibata, Professor, Nagoya Institute Of Technology, Japan

Dwo Yuan Sia, Chief Technology Officer, BravoVax Co Ltd, China

Jaspreet Singh, Vice President of Quality, Intas Pharmaceutical Ltd, India

Jaspreet Singh at Phar-East 2018

Sebastian Sujka, CEO & Co-Founder, Xbird, Bayer’s Grants4Apps, Germany

Crystal Sun, CEO Assistant & Director, Regulatory & Government Affairs, Fosun Kite Biotechnology, China

Kazuo Suzuki, Professor, Asia International Institute of Infectious Disease Control, Teikyo University, Japan

Bien Kiat Tan, Founder, Titan Capital, Singapore

Toshio Tanaka, Professor Pharmacogenomics Graduate School of Medicine, Mie University Hospital, Japan

I-Ning Tang, Senior Reviewer, Center For Drug Evaluation, Taiwan

Vincenzo Teneggi, Senior Medical Director, D3, Singapore

Han Chong Toh, Chief Medical Officer, Tessa Therapeutics, Singapore

Karen Tseng, CEO, Bio Preventive Medicine, Taiwan

Samir Varma, Head of Manufacturing, Enzene Biosciences, India

Damien Villeneuve, VP Business Development | Licensing – M&A, Asia-Pacific and Japan K.K., Lupin, Japan

Marc Voigt, Chief Executive Officer, Immutep Ltd, Australia

Marc Voigt at Phar-East 2018

Qun Wang, Director, R&D, Changchun Changsheng Life Sciences Ltd, China

Christian Wards, Director of Group Healthcare, AIA China, Hong Kong

Jack Wong, Head of Regulatory Affairs, Baxter Corp, Singapore

Dong-Hun Woo, CTO, Nexel, Republic Of Korea

Lei Xiao, Founder, President and Chief Strategy Officer, Innovative Cellular Therapeutics Company, China

Chung-Lin Yang, Team Leader, Division of Health Technology Assessment, Center For Drug Evaluation, Taiwan

Danny Yeung, Chief Executive Officer, Prenetics, Hong Kong

Jin-San Yoo, President And Chief Executive Officer, PharmAbcine, Republic Of Korea

Ko-eun Yoon, Business Development Assistant Manager, Daewoong Pharmaceutical Co Ltd, Republic Of Korea

John Zeng, Executive Vice President, Shanghai Zerun Biotechnology Co Ltd, China

John Zeng at Phar-East 2018

Mike Zhang, CEO, Liaoning Chengda Biotechnology Co.,Ltd., China

Joe Zhou, Chief Executive Officer, Genor BioPharma, Walvax Group, China

John Zhu, Partner, Wuxi Hi-Tech Venture Capital Co. Ltd., China

John Zhu at Phar-East 2018






For speaking, sponsorship and exhibition opportunities contact pinky.fadullon@terrapinn.com
Tel: +65 6322 2738